Портал на Пациента


Множествен миелом | Източници

По темите в раздел Множествен миелом са използвани материали от следните източници:

1 WebMD. Multiple myeloma. Available at:  https://www.webmd.com/cancer/multiple-myeloma-symptoms-causes-treatment#1. Accessed May 05, 2020.

2 National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Multiple myeloma. V.3.2018. Accessed at www.nccn.org on Dec. 7, 2017.

Munshi NC, Anderson KC. Ch. 112 Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 10th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.

Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046-1060.

American Cancer Society. What Is Multiple Myeloma? Available at: https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-myeloma.html. Accessed May 05, 2020.

3 Medicinenet. Multiple Myeloma. Medical Author: Charles Patrick Davis, MD, PhD Medical Editor: William C. Shiel Jr., MD, FACP, FACR. Available at: https://www.medicinenet.com/multiple_myeloma/article.htm. Accessed May 05, 2020.

4 GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.

5 Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (July 2009). “Multiple myeloma”. Lancet. 374 (9686): 324–39. doi:10.1016/S0140-6736(09)60221-X. PMID 19541364.

6 “Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Health Professional Version”. NCI. July 29, 2016. Archived from the original on 4 July 2016. Retrieved 8 August 2016.

7 World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 2.3 and 2.6. ISBN 978-9283204299.

8 Mayo Clinic. Multiple myeloma Diagnosis and Treatment. Available at: https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/diagnosis-treatment/drc-20353383. Accessed May 05, 2020.

9  Mayo Clinic. Multiple myeloma Overview. Available at: https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378. Accessed May 05, 2020.

10 Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (28 May 2009). “Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study”. Blood. 113 (22): 5412–7. doi:10.1182/blood-2008-12-194241. PMC 2689042. PMID 19179464

11 Dutta AK, Hewett DR, Fink JL, Grady JP, Zannettino AC (2017). “Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma”. British Journal of Haematology. 178 (2): 196–208. doi:10.1111/bjh.14649. PMID 28466550

12 Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Myeloma. National Cancer Institute. Available at http://seer.cancer.gov/statfacts/html/mulmy.html. Accessed: July 12, 2019.

13 Bataille R, Boccadoro M, Klein B, Durie B, Pileri A. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood. 1992 Aug 1. 80(3):733-7.

Този материал не е предназначен за здравни специалисти и е наличен за обществото само с информационна цел. Същият не трябва да бъде използван за поставяне на диагноза или лечение на здравословен проблем или заболяване. Материалът не е предназначен да замести консултация с лекар. При нужда от съвет, моля консултирайте се с Вашия лекуващ лекар.